Dr. Scott D. Lane

powered by
COS Expertise®
University of Texas Health Science Center at Houston
Medical School
Psychiatry and Behavioral Sciences
Graduate School of Biomedical Sciences
Associate Professor
Professional Headshot of Scott D. Lane

Mailing Address

Department of Psychiatry & Behavioral Sciences
University of Texas - Houston Health Science Center
1300 Moursund St.
Houston, Texas 77030
United States

Contact Information

Phone: (713) 500-2535
Fax: (713) 500-2618
scott.d.lane@uth.tmc.edu
http://webspace.uth.tmc.edu/slane/public/SDL_CV_2007.pdf

Qualifications

Ph.D., Auburn University, Psychology, 1995.
B.A., Whitman College, Psychology, 1988.

Expertise and Research Interests

Primary research interests:
Human psychopharmacology (as related to)
- Risky decision making
- Aggression / social interaction
- Impulsivity
- Substance abuse

Other Expertise

Postdoctoral Fellowship, University of Texas Health Science Center at Houston, Psychopharmacology, 1996

Future Research

Neural correlates of alcohol effects on aggression
Psychopharmacology of adenosine-2 antagonists in cocaine dependence

Keywords

COS Keywords:

Adolescents, Aggression, At-Risk Children or Youth, Behavioral Medicine, Behavioral Pharmacology, Decision Sciences, Drug Abuse Treatment, Drugs or Drug Abuse, Experimental Psychology, Human Learning and Memory, Psychiatry, Psychopharmacology.

Additional Terms:

Aggression / Social Intereaction, Decision Making, Functional MRI, Impulsivity, Psychopharmacology, Risk Taking.

Memberships

American Association for the Advancement of Science
American Psychological Association
Association for Behavior Analysis
College on Problems of Drug Dependence
Psychonomic Society
Sigma Xi, The Scientific Research Society
Society for the Quantitative Analysis of Behavior

Honors and Awards

2007-2008, NIH Study Section, National Institutes of Health, Risk Prevention and Intervention in Addiction
2007, Reviewer, Netherlands Organization for Health Research and Development, Section on High Risk Behavior and Dependency
2006, Fellow, American Psychological Association (APA)
2006-2007, NIH Study Section, National Institute on Drug Abuse, NIDA-K Training and Fellowship Committee
2006, Reviewer, US-Israeli Binational Science Foundation, Division of Cognitive and Decision Sciences
2004-2005, NIH Study Section, National Institute of Mental Health, Division of Neuroscience and Basic Behavioral Science
2003-2006, Board of Editors, Addictive Disorders and Their Treatments
2002-2005, Board of Editors, Journal of the Experimental Analysis of Behavior
2001, Wyeth-Ayerst Young Psychopharmacologist Award, American Psychological Association (APA), Div 28
1988, Academic Honor Socitey, Phi Kappa Phi

Funding Received

  • National Institutes of Health (NIH)/NIDA: Drugs of Abuse and Aggressive Behavior (PI), $175,000/yr, 2007 to 2012.
  • National Institutes of Health (NIH)/NIDA: Contingency Management plus Levodopa/Carbidopa for Treatment of Cocaine Dependence (Co-I), $250,000/yr, 2007 to 2011.
  • National Institutes of Health (NIH)/NIDA: PharmacoMRI, impulse control, and cue reactivity in cocaine dependence (Co-I), $120,000/yr, 2006 to 2008.
  • National Institutes of Health (NIH)/NIDA: Mechanisms in Risk Taking: Disinhibitory Drugs of Abuse (PI), $125,000/yr, 2002 to 2007.
  • National Institutes of Health (NIH)/NIDA: Marijuana Effects on Basic Behavioral Processes (PI), $125,000/yr, 2000 to 2005.
  • National Institutes of Health (NIH)/NIDA: Drugs of Abuse and Aggressive Behavior (Co-I), $200,000/yr, 2000 to 2005.
  • National Institutes of Health (NIH)/NIDA: Altering Behavioral Risk for Drug Dependence (Co-I), $138,000/yr, 1998 to 2003.
  • National Institutes of Health (NIH)/NIDA: Behavioral Mechanisms in High Risk Populations (Co-I), $105,000/yr, 1997 to 2002.
  • National Institutes of Health (NIH)/NIDA: Effects Marijuana of on Maladaptive Behavior Patterns (PI), $50,000/yr, 1997 to 1998.

Publications

  • Moeller FG, Steinberg JL, Lane SD, Buzby M, Swann AC, Hasan KM, Kramer LA, Narayana PA (Nov 2007) Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making., 33 (6), 777-789 Abstract
  • Lane SD, Cherek DR, Nouvion SO (Oct 2007) Modulation of human risky decision making by flunitrazepam. Abstract
  • Lieving LM, Cherek DR, Lane SD, Tcheremissine OV, Nouvion S (Aug 2007) Effects of acute tiagabine administration on aggressive responses of adult male parolees. Abstract
  • Lane SD, Moeller FG, Steinberg JL, Buzby M, Kosten TR (2007) Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty., The American journal of drug and alcohol abuse, 33 (5), 717-26 Abstract
  • Lane SD, Yechiam E, Busemeyer JR (May 2006) Application of a computational decision model to examine acute drug effects on human risk taking., Experimental and clinical psychopharmacology, 14 (2), 254-64 Abstract
  • Lane SD, Tcheremissine OV, Lieving LM, Nouvion S, Cherek DR (Sep 2005) Acute effects of alprazolam on risky decision making in humans., Psychopharmacology, 181 (2), 364-73 Abstract
  • Lane SD, Cherek DR, Pietras CJ, Steinberg JL, Performance of Heavy Marijuana-smoking Adolescents on a Laboratory Measure of Motivation, Addictive Behaviors, 30(4), 815-28, May 2005 Abstract
  • Lane SD, Cherek DR, Tcheremissine OV, Lieving LM, Pietras CJ, Acute Marijuana Effects on Human Risk Taking, Neuropsychopharmacology, 30(4), 800-9, Apr 2005 Abstract
  • Lane SD, Cherek DR, Lieving LM, Tcheremissine OV, Marijuana Effects on Human Forgetting Functions, Journal of the Experimental Analysis of Behavior, 83(1), 67-83, Jan 2005 Abstract
  • Matthews SC, Simmons AN, Lane SD, Paulus MP, Selective Activation of the Nucleus Accumbens During Risk-taking Decision Making, Neuroreport, 15(13), 2123-7, Sep 2004 Abstract
  • Lane SD, Cherek DR, Pietras CJ, Tcheremissine OV, Alcohol Effects on Human Risk Taking, Psychopharmacology, 172(1), 68-77, Feb 2004 Abstract
  • Lane SD, Cherek DR, Marijuana Effects on Sensitivity to Reinforcement in Humans, Neuropsychopharmacology, 26(4), 520-9, Apr 2002 Abstract
  • Cherek DR, Lane SD, Pietras CJ, Steinberg JL, Effects of Chronic Paroxetine Administration on Measures of Aggressive and Impulsive Responses of Adult Males With a History of Conduct Disorder, Psychopharmacology, 159(3), 266-74, Jan 2002 Abstract
  • Lane SD, Cherek DR, Risk Taking By Adolescents With Maladaptive Behavior Histories, Experimental and Clinical Psychopharmacology, 9(1), 74-82, February 2001 Abstract
  • Lane SD, Cherek DR, Analysis of risk taking in adults with a history of high risk behavior, Drug and Alcohol Dependence, 60(2), 179-87, 1 Aug 2000 Abstract
  • Cherek DR, Lane SD (Oct 1999) Effects of d,l-fenfluramine on aggressive and impulsive responding in adult males with a history of conduct disorder., Psychopharmacology, 146 (4), 473-81 Abstract
  • Nouvion SO, Cherek DR, Lane SD, Tcheremissine OV, Lieving LM, Human proactive aggression: association with personality disorders and psychopathy., Aggressive behavior, 33 (6), 552-62 Abstract

Profile Details

Last Verified: 11/13/2007

COS Expertise ID #955038
Reference this profile directly: http://myprofile.cos.com/s_lane